Roger R. Blunt

Director/Board Member at Fyodor Biotechnologies, Inc.

Health Technology

Profile

Roger R.
Blunt currently works at Fyodor Biotechnologies, Inc., as Non-Executive Director.

Companies	Position	Start
Fyodor Biotechnologies, Inc. Fyodor Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Fyodor Biotechnologies, Inc. is a healthcare company based in Baltimore, MD. Fyodor Biotechnologies has developed the Urine Malaria Test (UMT), which is the first and only non-blood test that tells in minutes if a fever is malaria, using a few drops of urine. The UMT is a disruptive innovation for malaria testing backed by top-rate science, and validated in a highly acclaimed pivotal clinical trial. The company's goal is to make it possible to test or be tested for malaria fast, at home or at a healthcare facility, and be promptly treated with over-the-counter antimalarial medicine. The company was founded by Eddy C. Agbo, who has been the CEO since incorporation.	Director/Board Member	-

Active

Inactive

Listed companies

Private companies

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

Private companies	1
Fyodor Biotechnologies, Inc. Fyodor Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Fyodor Biotechnologies, Inc. is a healthcare company based in Baltimore, MD. Fyodor Biotechnologies has developed the Urine Malaria Test (UMT), which is the first and only non-blood test that tells in minutes if a fever is malaria, using a few drops of urine. The UMT is a disruptive innovation for malaria testing backed by top-rate science, and validated in a highly acclaimed pivotal clinical trial. The company's goal is to make it possible to test or be tested for malaria fast, at home or at a healthcare facility, and be promptly treated with over-the-counter antimalarial medicine. The company was founded by Eddy C. Agbo, who has been the CEO since incorporation.	Health Technology

Private companies

Health Technology